New hope for Late-Arriving stroke patients: Fast-Acting drug trial opens
Disease control
Not yet recruiting
This trial is testing a new, fast-acting clot-busting drug for people who have an ischemic stroke but arrive at the hospital too late for standard treatment. It aims to see if a single, quick injection given 4.5 to 24 hours after symptoms start can help patients recover better. T…
Phase: PHASE3 • Sponsor: Supergene, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC